City-Wide Medical Grand Rounds: Organoids as potential vehicles for precision medicine

Organoids as potential vehicles for precision medicine

David Andrews, PhD

Director and Senior Scientist, Biological Sciences, Sunnybrook Research Institute
Professor, Departments of Biochemistry and Medical Biophysics, University of Toronto
Canada Research Chair in Membrane Biogenesis 

Learning Objectives:

At the end of the presentation, participants should be able to:

1. Recognize the concept of conditional reprogramming and how this differs from induced pluripotency.
2. Describe what an organoid is and how organoids can be used to study human physiology.
3. Summarize the use of organoids in drug development applications.
4. Predict the utility of organoids in clinical trials, diagnosis and treatment decisions.

Hosted at:

• University Health Network – Toronto General Hospital
  Medical Education, Eaton Ground 025/026

Interactive videoconference:

• Baycrest
  Telehealth boardroom
• Markham Stouffville
  A2317/18
• Michael Garron
  Gray Steele conference room
• Sinai Health
  Bridgepoint: G.001
  Mount Sinai Hospital: 18th floor auditorium
• St. Michael’s
  LKSKI: Keenan Research Centre auditorium - 2nd fl.
• Sunnybrook
  Bayview: McLaughlin Lecture Theatre, EG 61
  St. John's Rehab: S3 332
• Trillium Health Partners
  Credit Valley: ADMIN Meeting Room #1 (4F119)
  Mississauga: Enbridge Room
• University Health Network
  Toronto Western: Main auditorium, 2W 401
• West Park
  R3 Sunroom
• Women's College
  Auditorium, 2501

Webcast available

Questions will be accepted via email at uoft.cwmgr@gmail.com and Twitter.  

Evaluation & Attendance

Attendance for Maintenance of Certification credit will only be tracked if the evaluation and attendance surveys are completed.

CWMGR Poster - 18-05-16.pdf